HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Clinical trial NCT06149247 · COMPLETED

Trial details

NCT number: NCT06149247
Sponsor: Soligenix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Start date: 2023-12-05
Primary completion: 2024-05-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.